The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2022 | Implementing low-dose CT lung cancer screening
Matthijs Oudkerk, MD, PhD, University of Groningen, Groningen, Netherlands, discusses the implementation of low-dose computed tomography lung cancer screening, which has been demonstrated to notably reduce lung cancer mortality in high-risk populations. Prof. Oudkerk outlines what needs to be addressed to successfully implement lung cancer screening, including defining a recruitment strategy, rate of detection and false-positives, and radiation dose. This interview took place during the virtual European Lung Cancer Congress 2022.
